![]() |
|
|
Forward to a colleague |
||
Access Full Stories A new modular approach to automating laboratory techniques could ease the process of scaling small-scale manual methods to high-volume commercial production... Read Scientists wake up ancient Sleeping Beauty jumping gene Scientists have successfully created the first artificial transposon - a piece of DNA which randomly "jump" around the genome, cutting and pasting itself throughout the strands of DNA... Read EUR 15m project to uncover secrets of membrane proteins They play an important role in diseases such as diabetes and epilepsy but until now the structure and activity of proteins found in cell membranes have been little understood compared to proteins dissolved within... Read Biotech driving lab reagent market to 2010 The worldwide laboratory chemical reagents market is expected to reach $13.7bn by 2010, buoyed by the biotechnology sector, neuroscience research and proteomics... Read Affymetrix to outsource jobs to Singapore Microarray expert Affymetrix has started outsourcing some of its jobs in the US to Singapore... Read |
|||||||||||||||||
All News Headlines for: March | February | January |
|||||||||||||||||
|
Related Industry News inVentiv Clinical the latest CRO to go Latin inVentiv Clinical has become the latest contract research organisation (CRO) to open up shop in blossoming Latin America in a bid to gain more of a global reach... Read Hydrogel success calls for jolly good knees-up US scientists believe they may have uncovered an unusual material that has similar physical properties of gelatine, remaining intact even when deformed over 1,000 per cent... Read Crucell, DSM hit 15g/L milestone with PER.C6 technology Dutch biotech Crucell and its US partner DSM Biologics have achieved a record yield of 15 grams per litre with their PER.C6 cell line technology for the production of monoclonal antibodies and recombinant proteins... Read Emerging market challenges no hindrance to pharma Despite the challenges that emerging market present, such as intellectual property (IP) exposure and drug pricing controls, the pharma industry is not being deterred... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||